Skip to content
Application 202686
- Type
- ANDA
- Sponsor
- MYLAN LABS LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ESOMEPRAZOLE SODIUM | ESOMEPRAZOLE SODIUM | INJECTABLE;INTRAVENOUS | EQ 20MG BASE/VIAL | No | No |
| 002 | ESOMEPRAZOLE SODIUM | ESOMEPRAZOLE SODIUM | INJECTABLE;INTRAVENOUS | EQ 40MG BASE/VIAL | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 67457-392 | Esomeprazole sodium | Esomeprazole sodium | Mylan Institutional LLC | ANDA | Current |
| 67457-392 | Esomeprazole sodium | Esomeprazole sodium | Mylan Institutional LLC | ANDA | Current |
| 67457-392 | Esomeprazole sodium | Esomeprazole sodium | Mylan Institutional LLC | ANDA | Current |
| 67457-392 | Esomeprazole sodium | Esomeprazole sodium | Mylan Institutional LLC | ANDA | Current |
| 67457-392 | Esomeprazole sodium | Esomeprazole sodium | Mylan Institutional LLC | ANDA | Current |
| 67457-392 | Esomeprazole sodium | Esomeprazole sodium | Mylan Institutional LLC | ANDA | Current |